Browsing "1. Journal Papers" byAuthor : 298

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 13 of 13

This table browses all dspace content
Issue DateTitleJournal Title
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2017Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcomaAPMIS
2016Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma. YONSEI MEDICAL JOURNAL
2003Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinomaEUROPEAN UROLOGY
2015Leiomyosarcoma: investigation of prognostic factors for risk-stratification modelINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2016Prognostic implications of PD-L1 expression in patients with soft tissue sarcomaBMC CANCER
2016Prognostic implications of PIK3CA amplification in curatively resected liposarcoma ONCOTARGET
2018Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. BMC CANCER
2016Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience. JOURNAL OF CANCER
2017Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.CLINICAL NUCLEAR MEDICINE
1998Retroviral Vector를 이용한 Herpes Simplex Virus-Thymidine Kinase 유전자의 도입과 발현이 인체 위암세포주의 Ganciclovir 감수성에 미치는 영향 Journal of the Korean Cancer Association (대한암학회지)
2020Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma DIAGNOSTICS
2020Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells YONSEI MEDICAL JOURNAL
1

Browse

Links